Transcend Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,842
| Closed | -$222K | – | 497 |
|
|
2022
Q1 | $222K | Sell |
4,842
-3,525
| -42% | -$162K | 0.02% | 455 |
|
|
2021
Q4 | $512K | Buy |
8,367
+1,701
| +26% | +$104K | 0.05% | 296 |
|
|
2021
Q3 | $504K | Hold |
6,666
| – | – | 0.05% | 295 |
|
|
2021
Q2 | $613K | Buy |
6,666
+50
| +0.8% | +$4.6K | 0.09% | 187 |
|
|
2021
Q1 | $585K | Buy |
6,616
+1,629
| +33% | +$144K | 0.07% | 230 |
|
|
2020
Q4 | $465K | Buy |
4,987
+50
| +1% | +$4.66K | 0.06% | 242 |
|
|
2020
Q3 | $315K | Buy |
+4,937
| New | +$315K | 0.06% | 206 |
|